Articles From: ICF International Names Jim Lawler Senior Vice President for Human Resources to Investors Bet on Recovery in Oil Prices -- Update


ICF International (NASDAQ:ICFI), a leading provider of consulting services and technology solutions to government and commercial clients, has named Jim Lawler senior vice president for human resources (HR). Mr.
Sign-up for ICF International Names Jim Lawler Senior Vice President for Human Resources investment picks
FREMONT, Calif., Dec.
Sign-up for Identiv to Present at Imperial Capital's Security Investor Conference investment picks
- Clinical safety data for IMO-8400 support dose escalation in ongoing Phase 1/2 trials CAMBRIDGE, Mass., Dec.
Sign-up for Idera Pharmaceuticals Presents Data Supporting IMO-8400 as Novel Therapy for Genetically Defined Forms of B-Cell Lymphoma at Annual ASH Meeting investment picks
2014/12/8
IIROC Trade Resumption - FR Canada NewsWire TORONTO , Dec.
Sign-up for IIROC Trade Resumption - FR investment picks
2014/12/8
IIROC Trade Resumption - TLM Canada NewsWire TORONTO , Dec.
Sign-up for IIROC Trade Resumption - TLM investment picks
2014/12/8
IIROC Trading Halt - FR Canada NewsWire TORONTO , Dec.
Sign-up for IIROC Trading Halt - FR investment picks
2014/12/8
IIROC Trading Halt - PCY Canada NewsWire TORONTO , Dec.
Sign-up for IIROC Trading Halt - PCY investment picks
2014/12/8
IIROC Trading Halt - TLM Canada NewsWire TORONTO , Dec.
Sign-up for IIROC Trading Halt - TLM investment picks
2014/12/8
By Jason Ng KUALA LUMPUR--IJM Corp.
Sign-up for IJM To Sell Indian Highway Concession Unit in $85 Million Deal investment picks
- Note: This press release corresponds to abstracts 4453 and 4471 SAN FRANCISCO , Dec.
Sign-up for IMBRUVICA® (ibrutinib) Data Demonstrates Safety and Durability of Response at Two-Year Follow-up in Mantle Cell Lymphoma investment picks
2014/12/8
- Note: This press release corresponds to abstracts 627 and 1998.
Sign-up for IMBRUVICA® (ibrutinib) in Combination with Rituximab Data Shows Positive Benefit-Risk Profile in Hematologic Malignancy investment picks
2014/12/8
By Debiprasad Nayak MUMBAI--Indian shares fell Monday weighed by losses in technology bellwether Infosys Ltd.
Sign-up for India Shares Fall; Infosys Weighs As Founders Sell Stake investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today presented new preclinical translational data showing the complementary effects of inhibiting both PI3K-delta and PI3K-gamma , two enzymes known to play a role in regulating the growth and survival of certain types of potentially fatal blood cancers, including indolent non-Hodgkin lymphoma (iNHL) and chronic lymphocytic leukemia (CLL). This translational research also highlights the important role that PI3K-gamma plays in forming and maintaining the protective tumor microenvironment.
Sign-up for Infinity Reports New Translational Research and Updated Phase 1 Data of Investigational Oncology Compound Duvelisib at American Society of Hematology Annual Meeting investment picks
Redwood City, Calif., Dec.
Sign-up for Informatica to Present At CLSA Innovation Summit investment picks
2014/12/8
By Kenan Machado and Dhanya Ann Thoppil NEW DELHI--Some of the founders of Bangalore-based outsourcing major Infosys Ltd.
Sign-up for Infosys Founders Raise $1.05 Billion By Selling 2.8% Stake: Share Sale Manager investment picks
Ingles Markets, Incorporated (NASDAQ: IMKTA) today reported record sales of $3.84 billion for fiscal 2014, its 50 th consecutive year of sales growth.
Sign-up for Ingles Markets, Incorporated Reports 50th Year of Record Sales, Plus Growth in Sales and Net Income for Fourth Quarter investment picks
2014/12/8
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0983040001&sourceType=1 http://media3.marketwire.com/logos/20140207-InnVEST.jpg TORONTO, ONTARIO --
Sign-up for InnVest Real Estate Investment Trust Completes the Acquisition of the Hyatt Regency Vancouver investment picks
http://media.marketwire.com/attachments/201006/7704_InphiLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163478&ProfileId=051205&sourceType=1 SANTA CLARA, CA --
Sign-up for Inphi Announces New Speaking Time at Barclays Global Technology Conference investment picks
2014/12/8
This weekend, Intel® Extreme Masters, the ESL's elite global pro gaming tour since 2006 with over 4 million USD given out in prize money in eight seasons, took over the SAP Center in San Jose.
Sign-up for Intel Extreme Masters Gaming Tournament investment picks
Intercontinental Exchange (NYSE: ICE), the leading global network of exchanges and clearing houses, announced today that Jeffrey C.
Sign-up for Intercontinental Exchange Chairman and CEO to Present at Goldman Sachs US Financial Services Conference on December 10 investment picks
Intercontinental Exchange (NYSE: ICE), the leading global network of exchanges and clearing houses, announced today its intention to sell approximately 4.2 million shares in Euronext N.V., representing approximately 6% of Euronext’s share capital, by way of an accelerated book-building to institutional investors.
Sign-up for Intercontinental Exchange to Sell Remaining Shares in Euronext investment picks
2014/12/8
Touch-Free Smartphones, Organized Organ Donations, a Mobile-Enabled Energy Distribution Grid and a "Smart" Approach to Public Transportation are just a few of the Winning Ideas.
Sign-up for Introducing the Verizon Powerful Answers Award Winners for 2014 investment picks
Glancy Binkow & Goldberg LLP representing investors of Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ:SRPT) has filed a class action lawsuit in the United States District Court for the District of Massachusetts on behalf of a class (the “Class”) comprising purchasers of Sarepta securities between April 21, 2014 and October 27, 2014, inclusive (the “Class Period”). Please contact Lesley Portnoy or Casey Sadler at (888) 773-9224 or (310) 201-9150, or at shareholders@glancylaw.com to discuss this matter.
Sign-up for INVESTOR ALERT: Class Action Lawsuit Against Sarepta Therapeutics, Inc. Announced by Glancy Binkow & Goldberg LLP investment picks
Levi & Korsinsky is investigating the Board of Directors of Spansion, Inc. (“Spansion” or “the Company”) (NYSE: CODE) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Cypress Semiconductor Corporation (“Cypress”) (NasdaqGS: CY). Click here to learn more about the investigation: http://zlk.9nl.com/spansion-code .
Sign-up for INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Spansion, Inc. Regarding the Fairness of the Sale of the Company to Cypress Semiconductor Corp. -- CODE investment picks
2014/12/8
By Neena Rai LONDON--As oil prices continue to plunge, investors are already busy laying bets over a broader recovery in prices.
Sign-up for Investors Bet on Recovery in Oil Prices -- Update investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: ICF International Names Jim Lawler Senior Vice President for Human Resources to Investors Bet on Recovery in Oil Prices -- Update
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent